Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,689.66 +32.41 (+0.05%) CMC Crypto 200
1,425.02 -3.55 (-0.25%)
PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 35.81 |
| Open | 35.99 |
| Bid | 36.33 x 300 |
| Ask | 36.42 x 300 |
| Day's range | 35.88 - 36.82 |
| 52-week range | 17.53 - 45.68 |
| Volume | |
| Avg. volume | 882,025 |
| Market cap | 2.789B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.69 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 34.45 |
PR NewswirePTC Therapeutics to Participate at Upcoming Investor Conference
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference:
PR NewswirePTC Therapeutics Announces Validation of Sepiapterin European MAA
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the sepiapterin MAA for PKU has been validated and accepted for review by the EMA.
GuruFocus.comInsider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
Director Jerome Zeldis of PTC Therapeutics Inc (NASDAQ:PTCT) executed a sale of 20,000 shares of the company on May 22, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.